Update on Ph3 Program for #GeographicAtrophy Patients: Apellis expects to be able to restart enrollment of GA trials DERBY & OAKS in Q2 2019 and to have fully enrolled both studies by the end of Q1 2020, within originally planned timeline for completion: investors.apellis.com/news-releases/…

Hi all, Join complement biologist and Immunologist at ICW2023 Full programme available - still time to register! icw2023newcastle.co.uk/programme/ British Society for Immunology ImmunologyNorthEast